Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

18.34USD
24 Apr 2015
Change (% chg)

-- (--)
Prev Close
$18.34
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,635,752
52-wk High
$18.49
52-wk Low
$11.11

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company operates in three segments, including Cardiovascular, Rhythm Management and MedSurg. The Company’s cardiovascular segment includes Interventional Cardiology and... (more)

Overall

Beta: 1.10
Market Cap(Mil.): $24,560.58
Shares Outstanding(Mil.): 1,339.18
Dividend: --
Yield (%): --

Financials

Search Stocks

RPT-Wall St Week Ahead-Investors seek protection against healthcare stock decline

NEW YORK, April 24 - Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector.

26 Apr 2015

Investors seek protection against healthcare stock decline

NEW YORK - Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector.

25 Apr 2015

Investors seek protection against healthcare stock decline

NEW YORK - Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector.

25 Apr 2015

Wall St Week Ahead-Investors seek protection against healthcare stock decline

NEW YORK, April 24 - Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector.

25 Apr 2015

UPDATE 2-Boston Scientific gets U.S. OK for Watchman heart device

March 13 - Boston Scientific Corp said on Friday that the U.S. Food and Drug Administration approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation (AF).

14 Mar 2015

Boston Scientific gets U.S. OK for Watchman heart device

- Boston Scientific Corp said on Friday that the U.S. Food and Drug Administration approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation (AF).

14 Mar 2015

Boston Scientific wins U.S. approval for atrial fibrillation device

March 13 - Boston Scientific Corp said the U.S. Food and Drug Administration on Friday approved its device to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation.

14 Mar 2015

EU court rules Boston Scientific must pay pacemaker replacement surgery

BRUSSELS - U.S. medical device maker Boston Scientific Corp's German arm is liable for the cost of operations to replace potentially defective pacemakers, Europe's top court ruled on Thursday.

05 Mar 2015

EU court rules Boston Scientific must pay pacemaker replacement surgery

BRUSSELS, March 5 - U.S. medical device maker Boston Scientific Corp's German arm is liable for the cost of operations to replace potentially defective pacemakers, Europe's top court ruled on Thursday.

05 Mar 2015

Boston Scientific to buy Endo's urology portfolio for $1.65 billion

- Medical device maker Boston Scientific Corp said it will buy Endo International Plc's American Medical Systems' men's and prostate health business for up to $1.65 billion.

02 Mar 2015

Competitors

Earnings vs. Estimates

Search Stocks